A Phase Iii Trial (Zjbi0009): Cmaboo9 Plus Irinotecan Versus Irinotecan Alone As Second-Line Treatment After Fluoropyrimidine And Oxaliplatin Failure In Wild-Type K-Ras Metastatic Colorectal Cancer Patients.
JOURNAL OF CLINICAL ONCOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要